Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(3.72)
# 3,022
Out of 5,182 analysts
75
Total ratings
49.33%
Success rate
8.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANRO Alto Neuroscience | Reiterates: Buy | $50 | $22.78 | +119.49% | 3 | Apr 2, 2026 | |
| ASMB Assembly Biosciences | Reiterates: Buy | $50 | $28.42 | +75.93% | 3 | Mar 26, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Buy | $510 | $322.11 | +58.33% | 5 | Mar 25, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterates: Buy | $100 | $65.14 | +53.52% | 6 | Mar 25, 2026 | |
| ATAI AtaiBeckley | Reiterates: Buy | $25 | $3.64 | +586.81% | 3 | Mar 17, 2026 | |
| VYGR Voyager Therapeutics | Reiterates: Buy | $25 | $3.74 | +568.45% | 3 | Mar 17, 2026 | |
| ALT Altimmune | Maintains: Buy | $12 → $25 | $3.24 | +671.60% | 3 | Mar 16, 2026 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $5.73 | +1,208.90% | 2 | Mar 13, 2026 | |
| ALGS Aligos Therapeutics | Reiterates: Buy | $50 | $8.00 | +525.39% | 3 | Mar 11, 2026 | |
| QURE uniQure | Reiterates: Buy | $70 | $15.38 | +355.14% | 7 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $0.41 | +1,121.00% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $145 | $83.55 | +73.55% | 4 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $9.50 | +110.53% | 3 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $26.63 | +125.31% | 4 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $2.22 | +1,927.03% | 5 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $95 | $5.22 | +1,719.92% | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $70 | $21.53 | +225.13% | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $70 | $15.72 | +345.29% | 2 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $70 | $5.53 | +1,165.82% | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $28.89 | +90.38% | 3 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.25 | +3,880.89% | 2 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $31.05 | +222.06% | 2 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.75 | +471.43% | 1 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $0.93 | +975.27% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $1.76 | +468.18% | 3 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $27.43 | +191.65% | 2 | Oct 10, 2025 |
Alto Neuroscience
Apr 2, 2026
Reiterates: Buy
Price Target: $50
Current: $22.78
Upside: +119.49%
Assembly Biosciences
Mar 26, 2026
Reiterates: Buy
Price Target: $50
Current: $28.42
Upside: +75.93%
Alnylam Pharmaceuticals
Mar 25, 2026
Reiterates: Buy
Price Target: $510
Current: $322.11
Upside: +58.33%
Arrowhead Pharmaceuticals
Mar 25, 2026
Reiterates: Buy
Price Target: $100
Current: $65.14
Upside: +53.52%
AtaiBeckley
Mar 17, 2026
Reiterates: Buy
Price Target: $25
Current: $3.64
Upside: +586.81%
Voyager Therapeutics
Mar 17, 2026
Reiterates: Buy
Price Target: $25
Current: $3.74
Upside: +568.45%
Altimmune
Mar 16, 2026
Maintains: Buy
Price Target: $12 → $25
Current: $3.24
Upside: +671.60%
Silence Therapeutics
Mar 13, 2026
Reiterates: Buy
Price Target: $75
Current: $5.73
Upside: +1,208.90%
Aligos Therapeutics
Mar 11, 2026
Reiterates: Buy
Price Target: $50
Current: $8.00
Upside: +525.39%
uniQure
Mar 10, 2026
Reiterates: Buy
Price Target: $70
Current: $15.38
Upside: +355.14%
Mar 6, 2026
Maintains: Buy
Price Target: $10 → $5
Current: $0.41
Upside: +1,121.00%
Mar 4, 2026
Maintains: Buy
Price Target: $115 → $145
Current: $83.55
Upside: +73.55%
Mar 4, 2026
Maintains: Buy
Price Target: $15 → $20
Current: $9.50
Upside: +110.53%
Mar 3, 2026
Reiterates: Buy
Price Target: $60
Current: $26.63
Upside: +125.31%
Mar 3, 2026
Maintains: Buy
Price Target: $40 → $45
Current: $2.22
Upside: +1,927.03%
Mar 2, 2026
Maintains: Buy
Price Target: $55 → $95
Current: $5.22
Upside: +1,719.92%
Mar 2, 2026
Maintains: Buy
Price Target: $55 → $70
Current: $21.53
Upside: +225.13%
Mar 2, 2026
Maintains: Buy
Price Target: $35 → $70
Current: $15.72
Upside: +345.29%
Mar 2, 2026
Maintains: Buy
Price Target: $40 → $70
Current: $5.53
Upside: +1,165.82%
Feb 25, 2026
Reiterates: Buy
Price Target: $55
Current: $28.89
Upside: +90.38%
Feb 10, 2026
Reiterates: Buy
Price Target: $10
Current: $0.25
Upside: +3,880.89%
Feb 4, 2026
Reiterates: Buy
Price Target: $100
Current: $31.05
Upside: +222.06%
Dec 8, 2025
Initiates: Buy
Price Target: $10
Current: $1.75
Upside: +471.43%
Nov 17, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $0.93
Upside: +975.27%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $1.76
Upside: +468.18%
Oct 10, 2025
Reiterates: Buy
Price Target: $80
Current: $27.43
Upside: +191.65%